The bank holiday weekend brought the news that investment spending in the UK grew more than in any G7 country leading up to 2017. Following an outstanding climate for British business in 2017, the first quarter of 2018 has held form for the new tax year. IW Capital aims to support the UK investment community to fulfil a range of premium debt, equity, and EIS investment opportunities throughout 2018, with a keen focus on business expansion and strategic decision making. The news that UK investment spending surpassed the levels of its G7 counterparts for 2017 is testament to lead data from new IW research revealing a positive outlook for post-Brexit SME investment:
• 7.4 million investors say SMEs are more attractive as a result of increased trade prospects
• Over 25% of affluent investors feel more encouraged to invest in SMEs after Brexit
The crack-down on asset-backed EIS opportunities and the significant expansion of new-age sectors such as med-tech, biotech and fintech has impacted portfolio decisions for the 2018/2019 tax year significantly. Equally, the doubling of the EIS investment cap for knowledge-intensive companies, and the launch of a government consultation into a knowledge-intensive fund opens new doors for Britain’s top taxpayers to invest in progressive sectors.
As the lead and primary investor in peer to peer travel money platform WeSwap, IW Capital is proud to have been involved in leading this progressive charge in the fintech sector. In just four years, WeSwap has traded over £120 million as well as grown its user-base dramatically, expanding the range of currencies that can be exchanged on its platform and cementing its position at the forefront of UK ﬁntech innovation.
IW Capital is proud to support a selection of the UK’s promising scale-up case-studies, with our current live opportunity – Hill and Friends – garnering significant interest. To learn more about IW Capital’s upcoming investment opportunities ahead of the new tax year, speak to a member of our team on 020 7015 2250, or email email@example.com